Hikma Pharmaceuticals completes acquisition of Xellia's FDF business
(Alliance News) - Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form business. Denmark-based Xellia Pharmaceuticals ApS. Read More